Proceedings from the Turner Resource Network symposium: The crossroads of health care research and health care delivery

Philippe F. Backeljauw, Carolyn Bondy, Steven D. Chernausek, Joseph T. Cernich, David A. Cole, Laura P. Fasciano, Joan Foodim, Scott Hawley, David S. Hong, Rebecca C. Knickmeyer, Paul Kruszka, Angela E. Lin, Barbara M. Lippe, Gary A. Lorigan, Cheryl Maslen, Nelly Mauras, David C. Page, Victoria L. Pemberton, Siddharth K. Prakash, Charmian A. QuigleyKelly C. Ranallo, Allan L. Reiss, David E. Sandberg, Cindy Scurlock, Gary (Michael) Silberbach

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Turner syndrome, a congenital condition that affects ∼1/2,500 births, results from absence or structural alteration of the second sex chromosome. There has been substantial effort by numerous clinical and genetic research groups to delineate the clinical, pathophysiological, cytogenetic, and molecular features of this multisystem condition. Questions about the molecular-genetic and biological basis of many of the clinical features remain unanswered, and health care providers and families seek improved care for affected individuals. The inaugural "Turner Resource Network (TRN) Symposium" brought together individuals with Turner syndrome and their families, advocacy group leaders, clinicians, basic scientists, physician-scientists, trainees and other stakeholders with interest in the well-being of individuals and families living with the condition. The goal of this symposium was to establish a structure for a TRN that will be a patient-powered organization involving those living with Turner syndrome, their families, clinicians, and scientists. The TRN will identify basic and clinical questions that might be answered with registries, clinical trials, or through bench research to promote and advocate for best practices and improved care for individuals with Turner syndrome. The symposium concluded with the consensus that two rationales justify the creation of a TRN: inadequate attention has been paid to the health and psychosocial issues facing girls and women who live with Turner syndrome; investigations into the susceptibility to common disorders such as cardiovascular or autoimmune diseases caused by sex chromosome deficiencies will increase understanding of disease susceptibilities in the general population.

Original languageEnglish (US)
Pages (from-to)1962-1971
Number of pages10
JournalAmerican Journal of Medical Genetics, Part A
Volume167
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Turner Syndrome
Health Services Research
Delivery of Health Care
Sex Chromosomes
Genetic Research
Social Conditions
Disease Susceptibility
Practice Guidelines
Cytogenetics
Health Personnel
Autoimmune Diseases
Registries
Molecular Biology
Consensus
Cardiovascular Diseases
Clinical Trials
Parturition
Organizations
Physicians
Health

Keywords

  • Chromosome
  • Congenital heart disease
  • Genetics
  • Monosomy X
  • Neurodevelopment
  • Quality of life
  • Sex chromosomes
  • Turner syndrome
  • Women
  • Women's health

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Proceedings from the Turner Resource Network symposium : The crossroads of health care research and health care delivery. / Backeljauw, Philippe F.; Bondy, Carolyn; Chernausek, Steven D.; Cernich, Joseph T.; Cole, David A.; Fasciano, Laura P.; Foodim, Joan; Hawley, Scott; Hong, David S.; Knickmeyer, Rebecca C.; Kruszka, Paul; Lin, Angela E.; Lippe, Barbara M.; Lorigan, Gary A.; Maslen, Cheryl; Mauras, Nelly; Page, David C.; Pemberton, Victoria L.; Prakash, Siddharth K.; Quigley, Charmian A.; Ranallo, Kelly C.; Reiss, Allan L.; Sandberg, David E.; Scurlock, Cindy; Silberbach, Gary (Michael).

In: American Journal of Medical Genetics, Part A, Vol. 167, No. 9, 01.09.2015, p. 1962-1971.

Research output: Contribution to journalArticle

Backeljauw, PF, Bondy, C, Chernausek, SD, Cernich, JT, Cole, DA, Fasciano, LP, Foodim, J, Hawley, S, Hong, DS, Knickmeyer, RC, Kruszka, P, Lin, AE, Lippe, BM, Lorigan, GA, Maslen, C, Mauras, N, Page, DC, Pemberton, VL, Prakash, SK, Quigley, CA, Ranallo, KC, Reiss, AL, Sandberg, DE, Scurlock, C & Silberbach, GM 2015, 'Proceedings from the Turner Resource Network symposium: The crossroads of health care research and health care delivery', American Journal of Medical Genetics, Part A, vol. 167, no. 9, pp. 1962-1971. https://doi.org/10.1002/ajmg.a.37121
Backeljauw, Philippe F. ; Bondy, Carolyn ; Chernausek, Steven D. ; Cernich, Joseph T. ; Cole, David A. ; Fasciano, Laura P. ; Foodim, Joan ; Hawley, Scott ; Hong, David S. ; Knickmeyer, Rebecca C. ; Kruszka, Paul ; Lin, Angela E. ; Lippe, Barbara M. ; Lorigan, Gary A. ; Maslen, Cheryl ; Mauras, Nelly ; Page, David C. ; Pemberton, Victoria L. ; Prakash, Siddharth K. ; Quigley, Charmian A. ; Ranallo, Kelly C. ; Reiss, Allan L. ; Sandberg, David E. ; Scurlock, Cindy ; Silberbach, Gary (Michael). / Proceedings from the Turner Resource Network symposium : The crossroads of health care research and health care delivery. In: American Journal of Medical Genetics, Part A. 2015 ; Vol. 167, No. 9. pp. 1962-1971.
@article{b5a45628f95c41ea9d705f6b715ec151,
title = "Proceedings from the Turner Resource Network symposium: The crossroads of health care research and health care delivery",
abstract = "Turner syndrome, a congenital condition that affects ∼1/2,500 births, results from absence or structural alteration of the second sex chromosome. There has been substantial effort by numerous clinical and genetic research groups to delineate the clinical, pathophysiological, cytogenetic, and molecular features of this multisystem condition. Questions about the molecular-genetic and biological basis of many of the clinical features remain unanswered, and health care providers and families seek improved care for affected individuals. The inaugural {"}Turner Resource Network (TRN) Symposium{"} brought together individuals with Turner syndrome and their families, advocacy group leaders, clinicians, basic scientists, physician-scientists, trainees and other stakeholders with interest in the well-being of individuals and families living with the condition. The goal of this symposium was to establish a structure for a TRN that will be a patient-powered organization involving those living with Turner syndrome, their families, clinicians, and scientists. The TRN will identify basic and clinical questions that might be answered with registries, clinical trials, or through bench research to promote and advocate for best practices and improved care for individuals with Turner syndrome. The symposium concluded with the consensus that two rationales justify the creation of a TRN: inadequate attention has been paid to the health and psychosocial issues facing girls and women who live with Turner syndrome; investigations into the susceptibility to common disorders such as cardiovascular or autoimmune diseases caused by sex chromosome deficiencies will increase understanding of disease susceptibilities in the general population.",
keywords = "Chromosome, Congenital heart disease, Genetics, Monosomy X, Neurodevelopment, Quality of life, Sex chromosomes, Turner syndrome, Women, Women's health",
author = "Backeljauw, {Philippe F.} and Carolyn Bondy and Chernausek, {Steven D.} and Cernich, {Joseph T.} and Cole, {David A.} and Fasciano, {Laura P.} and Joan Foodim and Scott Hawley and Hong, {David S.} and Knickmeyer, {Rebecca C.} and Paul Kruszka and Lin, {Angela E.} and Lippe, {Barbara M.} and Lorigan, {Gary A.} and Cheryl Maslen and Nelly Mauras and Page, {David C.} and Pemberton, {Victoria L.} and Prakash, {Siddharth K.} and Quigley, {Charmian A.} and Ranallo, {Kelly C.} and Reiss, {Allan L.} and Sandberg, {David E.} and Cindy Scurlock and Silberbach, {Gary (Michael)}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/ajmg.a.37121",
language = "English (US)",
volume = "167",
pages = "1962--1971",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Proceedings from the Turner Resource Network symposium

T2 - The crossroads of health care research and health care delivery

AU - Backeljauw, Philippe F.

AU - Bondy, Carolyn

AU - Chernausek, Steven D.

AU - Cernich, Joseph T.

AU - Cole, David A.

AU - Fasciano, Laura P.

AU - Foodim, Joan

AU - Hawley, Scott

AU - Hong, David S.

AU - Knickmeyer, Rebecca C.

AU - Kruszka, Paul

AU - Lin, Angela E.

AU - Lippe, Barbara M.

AU - Lorigan, Gary A.

AU - Maslen, Cheryl

AU - Mauras, Nelly

AU - Page, David C.

AU - Pemberton, Victoria L.

AU - Prakash, Siddharth K.

AU - Quigley, Charmian A.

AU - Ranallo, Kelly C.

AU - Reiss, Allan L.

AU - Sandberg, David E.

AU - Scurlock, Cindy

AU - Silberbach, Gary (Michael)

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Turner syndrome, a congenital condition that affects ∼1/2,500 births, results from absence or structural alteration of the second sex chromosome. There has been substantial effort by numerous clinical and genetic research groups to delineate the clinical, pathophysiological, cytogenetic, and molecular features of this multisystem condition. Questions about the molecular-genetic and biological basis of many of the clinical features remain unanswered, and health care providers and families seek improved care for affected individuals. The inaugural "Turner Resource Network (TRN) Symposium" brought together individuals with Turner syndrome and their families, advocacy group leaders, clinicians, basic scientists, physician-scientists, trainees and other stakeholders with interest in the well-being of individuals and families living with the condition. The goal of this symposium was to establish a structure for a TRN that will be a patient-powered organization involving those living with Turner syndrome, their families, clinicians, and scientists. The TRN will identify basic and clinical questions that might be answered with registries, clinical trials, or through bench research to promote and advocate for best practices and improved care for individuals with Turner syndrome. The symposium concluded with the consensus that two rationales justify the creation of a TRN: inadequate attention has been paid to the health and psychosocial issues facing girls and women who live with Turner syndrome; investigations into the susceptibility to common disorders such as cardiovascular or autoimmune diseases caused by sex chromosome deficiencies will increase understanding of disease susceptibilities in the general population.

AB - Turner syndrome, a congenital condition that affects ∼1/2,500 births, results from absence or structural alteration of the second sex chromosome. There has been substantial effort by numerous clinical and genetic research groups to delineate the clinical, pathophysiological, cytogenetic, and molecular features of this multisystem condition. Questions about the molecular-genetic and biological basis of many of the clinical features remain unanswered, and health care providers and families seek improved care for affected individuals. The inaugural "Turner Resource Network (TRN) Symposium" brought together individuals with Turner syndrome and their families, advocacy group leaders, clinicians, basic scientists, physician-scientists, trainees and other stakeholders with interest in the well-being of individuals and families living with the condition. The goal of this symposium was to establish a structure for a TRN that will be a patient-powered organization involving those living with Turner syndrome, their families, clinicians, and scientists. The TRN will identify basic and clinical questions that might be answered with registries, clinical trials, or through bench research to promote and advocate for best practices and improved care for individuals with Turner syndrome. The symposium concluded with the consensus that two rationales justify the creation of a TRN: inadequate attention has been paid to the health and psychosocial issues facing girls and women who live with Turner syndrome; investigations into the susceptibility to common disorders such as cardiovascular or autoimmune diseases caused by sex chromosome deficiencies will increase understanding of disease susceptibilities in the general population.

KW - Chromosome

KW - Congenital heart disease

KW - Genetics

KW - Monosomy X

KW - Neurodevelopment

KW - Quality of life

KW - Sex chromosomes

KW - Turner syndrome

KW - Women

KW - Women's health

UR - http://www.scopus.com/inward/record.url?scp=84939464999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939464999&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.37121

DO - 10.1002/ajmg.a.37121

M3 - Article

C2 - 25920614

AN - SCOPUS:84939464999

VL - 167

SP - 1962

EP - 1971

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 9

ER -